Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page no longer includes rheumatoid arthritis, related topics, or MedlinePlus Genetics sections.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded related topics including Rheumatoid arthritis and MedlinePlus Genetics, and updated the revision to v3.5.0. Deleted the previous revision note v3.4.3.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.0%

- Check44 days agoChange DetectedRemoved the Related Topics entries for 'Rheumatoid arthritis' and 'MedlinePlus Genetics' (and the related topics heading) from the study page.SummaryDifference0.1%

- Check58 days agoChange DetectedRheumatoid arthritis and MedlinePlus Genetics topic links were added, and the page version updated from v3.4.1 to v3.4.2. These are minor metadata updates that do not modify the study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedPublication entry added: the Lancet 2019 SELECT-MONOTHERAPY paper is now listed with revision 3.4.1. The previously listed Lancet 2019 Erratum entry has been removed.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.